Asset Details
Do you wish to reserve the book?
Drug-Sensitive FGFR2 Mutations in Endometrial Carcinoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Drug-Sensitive FGFR2 Mutations in Endometrial Carcinoma
Do you wish to request the book?
Drug-Sensitive FGFR2 Mutations in Endometrial Carcinoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Drug-Sensitive FGFR2 Mutations in Endometrial Carcinoma
2008
Overview
Oncogenic activation of tyrosine kinases is a common mechanism of carcinogenesis and, given the druggable nature of these enzymes, an attractive target for anticancer therapy. Here, we show that somatic mutations of the fibroblast growth factor receptor 2 (FGFR2) tyrosine kinase gene, FGFR2, are present in 12% of endometrial carcinomas, with additional instances found in lung squamous cell carcinoma and cervical carcinoma. These FGFR2 mutations, many of which are identical to mutations associated with congenital craniofacial developmental disorders, are constitutively activated and oncogenic when ectopically expressed in NIH 3T3 cells. Inhibition of FGFR2 kinase activity in endometrial carcinoma cell lines bearing such FGFR2 mutations inhibits transformation and survival, implicating FGFR2 as a novel therapeutic target in endometrial carcinoma.
Publisher
National Academy of Sciences,National Acad Sciences
Subject
/ Animals
/ Cancer
/ Cells
/ Endometrial Neoplasms - drug therapy
/ Endometrial Neoplasms - genetics
/ Endometrial Neoplasms - metabolism
/ Female
/ fibroblast growth factor receptor 2
/ Fibroblast growth factor receptors
/ Genes
/ Kinases
/ MEDICIN
/ MEDICINE
/ Mice
/ Mutation
/ oncogene
/ Oncology
/ Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors
/ Receptor, Fibroblast Growth Factor, Type 2 - genetics
/ Receptor, Fibroblast Growth Factor, Type 2 - metabolism
/ Tumors
/ tyrosine
